The Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Small Cell Lung Carcinoma 71%
3. Non-Small Cell Lung Carcinoma 64%
4. Neoplasms 44%
5. Cell Line 39%
6. Tumor Suppressor Genes 25%
7. Genes 25%
8. Lung 23%
9. Mutation 22%
10. Methylation 20%
11. Adenocarcinoma of Lung 18%
12. Loss of Heterozygosity 15%
13. Chromosomes 14%
14. Growth 13%
15. Epithelial Cells 12%
16. Breast Neoplasms 12%
17. Survival 11%
18. Oncogenes 11%
19. Tumor Cell Line 11%
20. ErbB Receptors 11%
21. Hybrid Cells 10%
22. Proteins 10%
23. Gene Expression 10%
24. Therapeutics 9%
25. Small Cell Carcinoma 9%
26. Drug Therapy 8%
27. Carcinogenesis 8%
28. Alleles 8%
29. DNA 7%
30. Genome 7%
31. In Vitro Techniques 7%
32. Smokers 7%
33. Biomarkers 6%
34. Heterografts 6%
35. Phenotype 6%
36. Squamous Cell Carcinoma 6%
37. Epigenomics 6%
38. Carcinoma 6%
39. Human Chromosomes 6%
40. Protein-Tyrosine Kinases 6%
41. Monoclonal Antibodies 6%
42. myc Genes 5%
43. Epithelial-Mesenchymal Transition 5%
44. Apoptosis 5%
45. Clone Cells 5%
46. Bronchogenic Carcinoma 5%
47. Neoplasm Metastasis 5%
48. Messenger RNA 5%
49. Neuroendocrine Tumors 5%
50. Epithelium 5%
51. p53 Genes 5%
52. Pharmaceutical Preparations 5%
53. Exons 5%